Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis

H. G. Otten*, M. R. Daha, R. J E M Dolhain, H. H. De Rooy, F. C. Breedveld

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

To investigate the origin of circulating rheumatoid factor (RF) and the relation between RF production at different sites in patients with rheumatoid arthritis (RA), mononuclear cells derived from bone marrow, synovium and peripheral blood of patients with RA were examined for the presence of plasma cells and for their capacity to produce RF and other immunoglobulins in vitro. Analysis of culture supernatants for the presence of immunoglobulins demonstrated that cells derived from bone marrow, synovium and peripheral blood were all found to be capable of producing every immunoglobulin and RF isotype investigated. No significant correlations were found between concentrations of immunoglobulin isotypes produced by cells derived from different sites of one individual. Significant correlations were found, however, between concentrations of RF isotypes produced by cells derived from the three sites. These results indicate that the production of RF in the different compartments is not an autonomously regulated process. Mononuclear cells derived from bone marrow were found to be able to produce RF in similar quantities to cells dissociated from synovial tissue. In combination with the fact that circulating immunoglobulins are produced mainly in the bone marrow, this observation suggests that bone marrow is also a major source of circulating RF.

Original languageEnglish
Pages (from-to)236-240
Number of pages5
JournalClinical and Experimental Immunology
Volume94
Issue number2
Publication statusPublished - 1 Jan 1993

Keywords

  • bone marrow
  • rheumatoid arthritis
  • rheumatoid factor

Fingerprint

Dive into the research topics of 'Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this